NCT01990118View on ClinicalTrials.gov

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

May 31, 2006

Conditions
End Stage Renal Failure
Interventions
DRUG

Neoral

Neoral® capsule containing 25mg or 100mg cyclosporine

DRUG

Gengraf® capsule containing 25mg or 100mg cyclosporine

Transplant patients who were stable on Neoral were converted to Gengraf

Trial Locations (1)

10990

Clinical Research Centre, Penang Hospital, George Town

All Listed Sponsors
lead

Penang Hospital, Malaysia

OTHER_GOV

NCT01990118 - Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients | Biotech Hunter | Biotech Hunter